Injectable in situ crosslinkable RGD-modified alginate matrix for endothelial cells delivery.

Cell-based therapies offer an attractive approach for revascularization and regeneration of tissues. However, and despite the pressing clinical needs for effective revascularization strategies, the successful immobilization of viable vascular cells within 3D matrices has been difficult to achieve. In this paper the in vitro potential of a natural, injectable RGD-alginate hydrogel as an in situ forming matrix to deliver endothelial cells was evaluated. Several techniques were employed to investigate how these microenvironments could influence the behavior of vascular cells, namely their ability to promote the outward migration of viable, proliferative cells, retaining the ability to form a 3D arrangement. Cells within RGD-grafted alginate hydrogel were able to proliferate and maintained 80% of viability for at least 48 h post-immobilization. Additionally, entrapped cells created a 3D organization into cellular networks and, when put in contact with matrigel, cells migrated out of the RGD-matrix. Overall, the obtained results support the idea that the RGD peptides conjugated to alginate provide a 3D environment for endothelial cells adhesion, survival, migration and organization.

[1]  Rui L Reis,et al.  Crosstalk between osteoblasts and endothelial cells co-cultured on a polycaprolactone-starch scaffold and the in vitro development of vascularization. , 2009, Biomaterials.

[2]  M. Barbosa,et al.  Characterization of Polymeric Solutions as Injectable Vehicles for Hydroxyapatite Microspheres , 2010, AAPS PharmSciTech.

[3]  Rui L Reis,et al.  Contribution of outgrowth endothelial cells from human peripheral blood on in vivo vascularization of bone tissue engineered constructs based on starch polycaprolactone scaffolds. , 2009, Biomaterials.

[4]  David J Mooney,et al.  Upregulation of bone cell differentiation through immobilization within a synthetic extracellular matrix. , 2007, Biomaterials.

[5]  E. Place,et al.  Complexity in biomaterials for tissue engineering. , 2009, Nature materials.

[6]  G. Yancopoulos,et al.  Angiopoietin-2 functions as an autocrine protective factor in stressed endothelial cells , 2006, Proceedings of the National Academy of Sciences.

[7]  R. Soares,et al.  Immobilization of human mesenchymal stem cells within RGD-grafted alginate microspheres and assessment of their angiogenic potential. , 2010, Biomacromolecules.

[8]  Donald E. Ingber,et al.  Adhesion-dependent control of matrix metalloproteinase-2 activation in human capillary endothelial cells. , 2000, Journal of cell science.

[9]  Pol Maria Rommens,et al.  The effect of human osteoblasts on proliferation and neo-vessel formation of human umbilical vein endothelial cells in a long-term 3D co-culture on polyurethane scaffolds. , 2008, Biomaterials.

[10]  C. Jackson,et al.  Human endothelial gelatinases and angiogenesis. , 2001, The international journal of biochemistry & cell biology.

[11]  Robert Langer,et al.  Cell-responsive hydrogel for encapsulation of vascular cells. , 2009, Biomaterials.

[12]  V. Speirs.  Matrix metalloproteinases and angiogenesis , 2000, Breast Cancer Research.

[13]  A. Mikos,et al.  Crosslinking characteristics of and cell adhesion to an injectable poly(propylene fumarate-co-ethylene glycol) hydrogel using a water-soluble crosslinking system. , 2003, Tissue engineering.

[14]  J. Pober,et al.  Engineering of multifunctional gels integrating highly efficient growth factor delivery with endothelial cell transplantation , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  C. V. van Blitterswijk,et al.  Engineering vascularised tissues in vitro. , 2008, European cells & materials.

[16]  Glenn D Prestwich,et al.  Synthesis and evaluation of injectable, in situ crosslinkable synthetic extracellular matrices for tissue engineering. , 2006, Journal of biomedical materials research. Part A.

[17]  Eun-Suk Kim,et al.  Material-based deployment enhances efficacy of endothelial progenitor cells , 2008, Proceedings of the National Academy of Sciences.

[18]  Pedro L Granja,et al.  Molecularly designed alginate hydrogels susceptible to local proteolysis as three-dimensional cellular microenvironments. , 2011, Acta biomaterialia.

[19]  D J Mooney,et al.  Alginate hydrogels as synthetic extracellular matrix materials. , 1999, Biomaterials.

[20]  R. Harfouche,et al.  Signaling and regulation of endothelial cell survival by angiopoietin-2. , 2006, American journal of physiology. Heart and circulatory physiology.

[21]  J. Hubbell,et al.  Human embryonic stem cell-derived microvascular grafts for cardiac tissue preservation after myocardial infarction. , 2011, Biomaterials.

[22]  David J Mooney,et al.  Controlling alginate gel degradation utilizing partial oxidation and bimodal molecular weight distribution. , 2005, Biomaterials.

[23]  R. Bareille,et al.  The effect of the co-immobilization of human osteoprogenitors and endothelial cells within alginate microspheres on mineralization in a bone defect. , 2009, Biomaterials.

[24]  Randall J. Lee,et al.  The effect of injected RGD modified alginate on angiogenesis and left ventricular function in a chronic rat infarct model. , 2009, Biomaterials.

[25]  Richard T. Lee,et al.  Injectable Self-Assembling Peptide Nanofibers Create Intramyocardial Microenvironments for Endothelial Cells , 2005, Circulation.

[26]  P. Ma,et al.  Ionically crosslinked alginate hydrogels as scaffolds for tissue engineering: part 1. Structure, gelation rate and mechanical properties. , 2001, Biomaterials.

[27]  F. Bosman,et al.  Immunohistochemical Expression of Endothelial Markers CD31, CD34, von Willebrand Factor, and Fli-1 in Normal Human Tissues , 2006, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[28]  D. Stupack,et al.  Apoptotic cues from the extracellular matrix: regulators of angiogenesis , 2003, Oncogene.

[29]  C James Kirkpatrick,et al.  Tissue-like self-assembly in cocultures of endothelial cells and osteoblasts and the formation of microcapillary-like structures on three-dimensional porous biomaterials. , 2007, Biomaterials.

[30]  D. Mooney,et al.  Designing alginate hydrogels to maintain viability of immobilized cells. , 2003, Biomaterials.

[31]  Y. Fujio,et al.  Akt Mediates Cytoprotection of Endothelial Cells by Vascular Endothelial Growth Factor in an Anchorage-dependent Manner* , 1999, The Journal of Biological Chemistry.

[32]  H. Hall.  Modified fibrin hydrogel matrices: both, 3D-scaffolds and local and controlled release systems to stimulate angiogenesis. , 2007, Current pharmaceutical design.

[33]  D. Mooney,et al.  Hydrogels for tissue engineering: scaffold design variables and applications. , 2003, Biomaterials.

[34]  H. Augustin,et al.  The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies. , 2004, Blood.

[35]  A. Mikos,et al.  Development of Poly(Propylene Fumarate-co-Ethylene Glycol) as an Injectable Carrier for Endothelial Cells , 1999, Cell transplantation.